BeSt practice: The success of early-targeted treatment in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 30, Issue 4 SUPPL.73, 2012, Pages

  Van Den Broek, M ^a   Lems, W F ^b   Allaart, C F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Functional ability; Remission; Rheumatoid arthritis; Treat to target

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EARLY INTERVENTION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INFUSION RELATED REACTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; PATIENT CARE PLANNING; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SULFASALAZINE;

EID: 84870267035     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. GRIGOR C, CAPELL H, STIRLING A et al.: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.
2. VAN DER HEIJDE DM, VAN'T HOF M, VAN RIEL PL et al.: Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
3. VAN GESTEL AM, PREVOO ML, VAN'T HOF MA et al.: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
4. GOEKOOP-RUITERMAN YP, DE VRIES-BOUWSTRA JK, ALLAART CF et al.: Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
5. SIEGERT CE, VLEMING LJ, VAN DEN BROUCKE JP, CATS A: Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984;3:305-9.
6. VAN DER HEIJDE D: How to read radiographs according to the Sharp/van der Heijde method. Rheumatol 1999;26:743-5.
7. VAN DER KOOIJ SM, LE CESSIE S, GOEKOOP-RUITERMAN YP et al.: Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Ann Rheum Dis 2009;68:1153-8.
8. VAN DEN BROEK M, KLARENBEEK NB, DIRVEN L et al.: Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity scoresteered therapy: subanalysis of the BeSt study. Ann Rheum Dis 2011;70:1389-94.
9. DIRVEN L, VAN DEN BROEK M, KLARENBEEK NB et al.: Seven Year Results of DAS Steered Treatment in the BeSt Study: Clinical and Radiological Outcomes. Arthritis Rheum 2010;62(Suppl. 10):334.
10. VAN DER KOOI E, KLARENBEEK NB, GÜLER-YÜKSEL M et al.: A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study. Ann Rheum Dis 2011;70:168-71.
11. KLARENBEEK NB, GÜLER-YÜKSEL M, VAN DER KOOIJ SM et al.: The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study. Ann Rheum Dis 2011;70:1039-46.
12. VISSER K, GOEKOOP-RUITERMAN YP, DE VRIES-BOUWSTRA JK et al.: A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis 2010;69:1333-7.
13. VAN HULST LT, CREEMERS MC, FRANSEN J et al.: How to improve DAS28 use in daily clinical practice? - a pilot study of a nurse-led intervention. Rheumatology (Oxford) 2010;49:741-8.